Dublin, Jan. 26, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/9bkcr3/injectable_drug) has announced the addition of the "Injectable Drug Delivery Devices, Markets, Forecasts" report to their offering.
This report examines the key therapeutic, product, market and regulatory factors for injectable drugs across ten major disease and therapeutic classes, providing essential insight and forecasts into the implications of this evolving landscape.
The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them. This shift has fostered change on several levels of the healthcare sector. The injectable drug segment has seen a marked increase in the level of drug/device integration, as prefilled syringes and specialized injection devices proliferate in response to safety and economic challenges posed by recombinant protein drugs, while administration of injectables has moved increasingly from practitioner offices and healthcare facilities to patient homes.
What You Will Learn
- What injectable drugs are currently marketed, how are they administered, what are the device specifics, and who markets them?
- What are the injection device types that are driving the market? What is their market share and who are the leading suppliers?
- What new injection device classes have recently been launched and was is their probable impact going to be on the injectables sector?
- What does the injectable drugs supply chain consist of, who are the key suppliers, their manufacturing infrastructure and locations, their capabilities?
- What are the major factors driving injectable drug demand?
- How important are drug developer-device manufacturer relationships and what are the key alliances in the industry?
- What is the size & breakdown of the injectable drug market today? What will it look like in 2022?
Key Topics Covered:
1. Executive Summary
2. Injectable Drug Market Dynamics
- The Injectable Drug Ecosystem
- Injectable Drug Demand Drivers
- Drug Development Factors
- Market Factors
- Technology Factors
- Competitive Landscape
- Risks and Opportunities
3. Injectable Drug-Device Selection Criteria
- Stability and Material Selection Issues
- Single vs Multi-Dose Devices
- Lyophilized Drugs/Reconstitution
- Syringe Safety/Sharps Protection
- Needle Configuration Strategies
- Disposable Drug Cartridges
- Human Engineering/Ergonomics
- Branding/Private Labeling
4. Injectable Drug Delivery - Device Segments
- Autoinjectors
- Autoinjector-specific Selection Factors
- Autoinjector Device Categories
- Drugs and Therapeutic Segments
- Needle-free Injectors
- Device Categories
- Needle-free Injector-specific Selection Factor Pen Injectors
- Pen Injector Device Categories
- Branded Drug/Pen Injector Product by Segment
- Prefilled Syringe Device Categories
- Glass Prefilled Syringes
- Plastic Prefilled Syringes
- Safety Syringes
- Prefillable Integrated Safety Syringes
- Non-Prefillable Integrated Safety Syringes
- Wearable Injectors
- Patch Injectors
- Subcutaneous Infusion Devices
5. Injectable Drug Delivery - Therapeutic Segment
- Analysis & Forecasts
- Anaphylaxis
- Anticoagulants
- Antivirals
- Autoimmune Diseases
- Emergency Medicine
- Hematopoietics
- Hormone Replacement
- Metabolic Diseases
- Neurology
- Reproductive Health
- Vaccines
6. Injectable Drug Therapeutics - Market Factors
- Regulatory Factors and Issues
- Sharps Legislations
- Managed Care & Healthcare Economics
7. Company Profiles
For more information visit http://www.researchandmarkets.com/research/9bkcr3/injectable_drug
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 



